Home Podcasts NEJM Interviews
NEJM Interviews

NEJM Interviews

NEJM Group 939 Episodes Aug 19, 2026

Insightful conversations with leading experts in the field of health care, medical research, policy, and more from the New England Journal of Medicine (NEJM). Each episode examines the many complexities found at the junction of medicine and society.

Episodes

NEJM Interview: Rebecca Haffajee on the rescheduling of medical marijuana products and its potential effect on research.
NEJM Interview: Rebecca Haffajee on the rescheduling of medical marijuana products and its potential effect on research. Aug 19, 2026 13:08 Rebecca Haffajee is a professor in the Department of Health Policy and Management at the Yale School of Public Health. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. R.L. Haffajee, R.A. Mikos, and Z.D. Cooper. Marijuana Rescheduling — A Game Changer for Research? N Engl J Med 2026;395:729-731.
NEJM Interview: Eric Schneider on the limitations of pay-for-performance programs and alternative options to support quality improvement.
NEJM Interview: Eric Schneider on the limitations of pay-for-performance programs and alternative options to support quality improvement. Aug 12, 2026 8:55 Eric Schneider is an adjunct professor of health policy and management at the Harvard T.H. Chan School of Public Health and a member of the Journal’s Perspective Advisory Board. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. M. Chernew and E.C. Schneider. Rethinking the Role of Pay for Performance in Federal Health Care Quality Programs. N Engl J Med 2026;3
NEJM Interview: Jean Nachega on the importance of investment in equitable partnerships, community trust, and local scientific leadership for outbreak preparedness.
NEJM Interview: Jean Nachega on the importance of investment in equitable partnerships, community trust, and local scientific leadership for outbreak preparedness. Aug 5, 2026 11:14 Jean Nachega is a professor of infectious diseases and the director of the Biomedical Research Institute at Stellenbosch University and an associate professor at the University of Pittsburgh School of Public Health. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. A. Zumla and Others. Ebola at 50 — Lessons for Outbreak Response and Preparedness. N Engl J Med
NEJM Interview: Jerry Avorn on the role of litigation in addressing product-related damage to health.
NEJM Interview: Jerry Avorn on the role of litigation in addressing product-related damage to health. Jul 29, 2026 14:12 Jerry Avorn is a professor of medicine at Harvard Medical School and the codirector of the Program on Regulation, Therapeutics, and Law at Harvard Medical School and Brigham and Women’s Hospital. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. J. Avorn. Products That Pose Health Risks — Can Litigation Protect Us When Government Fails? N Engl J Med 2026;395:4
NEJM Interview: Arnold Monto on the value and feasibility of various methods for evaluating the protection offered by vaccines.
NEJM Interview: Arnold Monto on the value and feasibility of various methods for evaluating the protection offered by vaccines. Jul 22, 2026 8:40 Arnold Monto is a professor emeritus of epidemiology and of public health and codirector of the Center for Respiratory Virus Research and Response at the University of Michigan School of Public Health. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. A.S. Monto and H.Y. Chu. The Best of Both Worlds — Using Clinical Trial and Observational Data to Evaluate Vac
NEJM Interview: Yaara Zisman-Ilani on navigating the uncertainty surrounding medication management in autism care.
NEJM Interview: Yaara Zisman-Ilani on navigating the uncertainty surrounding medication management in autism care. Jul 15, 2026 8:05 Yaara Zisman-Ilani is an associate professor in the Department of Social and Behavioral Sciences at the Barnett College of Public Health and in the Department of Psychiatry and Behavioral Science at the Lewis Katz School of Medicine, both at Temple University. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. Y. Zisman-Ilani and Others. Pharmacotherapeutic Dec
NEJM Interview: Mark Unruh on projected increases in the need for long-term services and supports in the United States amid declines in nursing-home capacity.
NEJM Interview: Mark Unruh on projected increases in the need for long-term services and supports in the United States amid declines in nursing-home capacity. Jul 8, 2026 5:40 Mark Unruh is an associate professor of population health sciences at Weill Cornell Medical College. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. M.A. Unruh, V. Mor, and H.-Y. Jung. Colliding Forces — The Aging of the Baby Boom Generation and Contracting Nursing-Home Supply. N Engl J Med 2026;395:105-107. A.R. Olenski and D.C. Grabowski. Caring for an Agi
NEJM Interview: Justin Barr on physician leadership in American society and politics over the past 250 years.
NEJM Interview: Justin Barr on physician leadership in American society and politics over the past 250 years. Jul 1, 2026 11:08 Justin Barr is a transplant surgeon at the Ochsner Clinic and a historian. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. S.H. Podolsky, D.S. Jones, and J. Barr. Declarations of Independence — Physicians and the U.S. Body Politic, 1776–2026. N Engl J Med 2026;395:1-3.
NEJM Interview: Stacie Dusetzina on a new program that will allow Medicare Part D enrollees to obtain GLP-1 medications for use for weight loss.
NEJM Interview: Stacie Dusetzina on a new program that will allow Medicare Part D enrollees to obtain GLP-1 medications for use for weight loss. Jun 24, 2026 13:06 Stacie Dusetzina is a professor of health policy and of cancer research at the Vanderbilt University School of Medicine. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. S.B. Dusetzina. Access to GLP-1s for Medicare Beneficiaries — A Bridge to Nowhere? N Engl J Med 2026;394:2385-2387.
NEJM Interview: Marcus Hughes on inconsistent oversight of psychedelic agents at the state and federal levels in the United States.
NEJM Interview: Marcus Hughes on inconsistent oversight of psychedelic agents at the state and federal levels in the United States. Jun 17, 2026 9:02 Marcus Hughes is an assistant professor of psychiatry at the Yale School of Medicine and an attending psychiatrist at Yale New Haven Psychiatric Hospital. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. M. Hughes. Psychedelic Therapies in the United States — Balancing State and Federal Oversight. N Engl J Med 2026;394:2281-2283. Y. Zisman-Ilani and R. Yehuda
NEJM Interview: Edward Ryan on factors driving continued disease and death from cholera and opportunities for progress.
NEJM Interview: Edward Ryan on factors driving continued disease and death from cholera and opportunities for progress. Jun 10, 2026 12:17 Edward Ryan is the director of global infectious diseases at Massachusetts General Hospital. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. E.T. Ryan, F. Qadri, and J.A. Lynch. Global Cholera-Control Efforts — Progress and Remaining Challenges. N Engl J Med 2026;394:2177-2180.
NEJM Interview: Loren Adler on regulatory strategies for addressing factors that make consolidation in health care especially profitable.
NEJM Interview: Loren Adler on regulatory strategies for addressing factors that make consolidation in health care especially profitable. Jun 3, 2026 10:14 Loren Adler is a fellow and the associate director at the Center on Health Policy at the Brookings Institution. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. L. Adler. Regulating Corporate Control in the U.S. Health Care System. N Engl J Med 2026;394:2073-2076.

Recommended